Univercells Technologies and Repligen have partnered to integrate real-time monitoring capabilities for glucose and lactate levels in viral vector and vaccine production. The collaboration incorporates Repligen’s MAVEN® Real Time Glucose Control Platform with Univercells' scale-X bioreactors, enabling non-disruptive, high-frequency sampling and improved process analytics technology (PAT). This integration streamlines cell culture process control, enhances data resolution, and may optimize media feeding and cellular growth strategies crucial to advanced therapy manufacturing.